Bioinspired inorganic nanoparticles-based mRNA antiviral vaccines

Acronym

BIGMAC

Description of the granted funding

New viruses or variants of known viruses will inevitably appear from time to time. Thus, it is extremely important to develop a novel versatile strategy for vaccine design to be prepared for the novel threats. The proposed project aims to develop robust bioinspired nanoplatforms for the delivery of mRNA with virus-like porous nanoparticles. In addition to defeating SARS-CoV-2, the bioinspired vaccine approach can be easily adapted by changing the mRNA delivered to fight emerging SARS-CoV-2 variants or other emerging viruses.
Show more

Starting year

2023

End year

2027

Granted funding


Wujun Xu Orcid -palvelun logo
496 224 €

Role in consortium of the Academy of Finland

Leader

Other consortium parties

Partner
University of Helsinki (356057)
496 031 €

Funder

Research Council of Finland

Funding instrument

Academy projects

Decision maker

Scientific Council for Natural Sciences and Engineering
06.06.2023

Other information

Funding decision number

356056

Fields of science

Materials engineering

Research fields

Biomateriaalit

Identified topics

covid, pandemic, vaccines